Skin Microbiome Modulator Market

The microbiome refers to the collection of all microbial species and their genetic information and functions that exist in a specific environment. It also includes the interaction between microbes and between microbes and the environment. It can be seen that the microbiome itself includes three aspects. One is different types of microorganisms, including bacteria, fungi and viruses, which corresponds to another commonly used term, Microbiota, microbiota; second, the genetic information and functions of these microorganisms Corresponding to it is Metagenome, which refers to the genes and genomes of microbes; third, the relationship between microbes and the environment. As far as current cognition is concerned, the human microbiota accounts for the majority in number and the most studied is bacteria, so many articles often replace the microbiota with microbiota.
Skin Microbiome Modulator Market contains market size and forecasts of Skin Microbiome Modulator in Global, including the following market information:
Global Skin Microbiome Modulator Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Skin Microbiome Modulator market was valued at 596.6 million in 2021 and is projected to reach US$ 1713.6 million by 2028, at a CAGR of 16.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Probiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Skin Microbiome Modulator include AOBiome, Azitra, Inc., Evelo Biosciences, Inc., GALLIN?E, Glowbiotics, Inc., Johnson & Johnson Services, Inc., L?Or?al S.A., MATRISYS BIOSCIENCE and Quorum Innovations, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Skin Microbiome Modulator companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Skin Microbiome Modulator Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Skin Microbiome Modulator Market Segment Percentages, by Type, 2021 (%)
Probiotics
Prebiotics
Drugs
Global Skin Microbiome Modulator Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Skin Microbiome Modulator Market Segment Percentages, by Application, 2021 (%)
Skin Care
Hair Care
Others
Global Skin Microbiome Modulator Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Skin Microbiome Modulator Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Skin Microbiome Modulator revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Skin Microbiome Modulator revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AOBiome
Azitra, Inc.
Evelo Biosciences, Inc.
GALLIN?E
Glowbiotics, Inc.
Johnson & Johnson Services, Inc.
L?Or?al S.A.
MATRISYS BIOSCIENCE
Quorum Innovations
Siolta Therapeutics
The Est?e Lauder Companies Inc.
Unilever